Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
mouse protection
Description:
An experimental measure of protection in mice following immunization or exposure to infectious agents, used particularly in vaccine and serum evaluation.
Related topics:
Bacterial Infections and Vaccines (10%),
Influenza Virus Research Studies (9%),
Mosquito-borne diseases and control (8%)
OpenAlex ID:
keywords/mouse-protection
A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence.
1989
·
S I Miller
, A M Kukral
, et al.
·
Proceedings of the National Academy of Sciences
·
1,059
A Simple Chemically Defined Medium for the Production of Phase I Bordetella pertussis
1970
·
D. W. Stainer
, M. J. Scholte
·
Journal of General Microbiology
·
671
Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence
1999
·
Patricia Mayville
, Guangyong Ji
, et al.
·
Proceedings of the National Academy of Sciences
·
506
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome
2006
·
Manuel J Rodríguez-Ortega
, Nathalie Norais
, et al.
·
Nature Biotechnology
·
459
Mutants of Pertussis Toxin Suitable for Vaccine Development
1989
·
Mariagrazia Pizza
, Antonio Covacci
, et al.
·
Science
·
327
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine
1998
·
David G. Heath
, George W. Anderson
, et al.
·
Vaccine
·
296
The FDA-approved drug sofosbuvir inhibits Zika virus infection
2016
·
Kristen M. Bullard-Feibelman
, Jennifer Govero
, et al.
·
Antiviral Research
·
263
Evaluation of a Genetically Modified Reassortant H5N1 Influenza A Virus Vaccine Candidate Generated by Plasmid-Based Reverse Genetics
2002
·
Kanta Subbarao
, Hualan Chen
, et al.
·
Virology
·
263
PDF
Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses
2001
·
Elena A. Govorkova
, Irina A. Leneva
, et al.
·
Antimicrobial Agents and Chemotherapy
·
260
Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon
1984
·
Albrecht F. Kiderlen
, Stefan H. E. Kaufmann
, et al.
·
European Journal of Immunology
·
240
Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).
1987
·
L S McDaniel
, J Yother
, et al.
·
The Journal of Experimental Medicine
·
229
PDF
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
2010
·
Gayathri Bommakanti
, Michael P. Citron
, et al.
·
Proceedings of the National Academy of Sciences
·
226
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis
1996
·
G W Anderson
, S E Leary
, et al.
·
Infection and Immunity
·
224
PDF
Production of Outer Membrane Vesicles and Outer Membrane Tubes by Francisella novicida
2012
·
W. D. McCaig
, A. Koller
, et al.
·
Journal of Bacteriology
·
217
Chimeric alphavirus vaccine candidates for chikungunya
2008
·
Eryu Wang
, Eugenia Volkova
, et al.
·
Vaccine
·
205
A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques
1980
·
Gerald Schiffman
, Robert M. Douglas
, et al.
·
Journal of Immunological Methods
·
201
Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague
1995
·
S E Leary
, E D Williamson
, et al.
·
Infection and Immunity
·
193
PDF
Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus
2006
·
Mark Throsby
, Cecile Geuijen
, et al.
·
Journal of Virology
·
189
A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene
1993
·
E.D. Williamson
, R.W. Titball
·
Vaccine
·
185
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide
1986
·
P B Fernandes
, R Bailer
, et al.
·
Antimicrobial Agents and Chemotherapy
·
172
Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections
2011
·
Annalisa Nuccitelli
, Roberta Cozzi
, et al.
·
Proceedings of the National Academy of Sciences
·
164
Streptococcus suisEnolase Functions as a Protective Antigen Displayed on the Bacterial Cell Surface
2009
·
Youjun Feng
, Xiuzhen Pan
, et al.
·
The Journal of Infectious Diseases
·
164
Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.
1971
·
R Schneerson
, L P Rodrigues
, et al.
·
PubMed
·
159
In Vivo Bioluminescent Imaging of Influenza A Virus Infection and Characterization of Novel Cross-Protective Monoclonal Antibodies
2013
·
Nicholas S. Heaton
, Victor H. Leyva-Grado
, et al.
·
Journal of Virology
·
158
Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers
2011
·
Samuel W. Gerritz
, Christopher Cianci
, et al.
·
Proceedings of the National Academy of Sciences
·
149
Show more works
View as search
Works count:
781
Citation count:
24,860
Year
Topic
Type